BIXT — Bioxytran Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Bioxytran, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.042	0.072	0.295	0.026	0.005
Prepaid Expenses
Total Current Assets	0.316	0.072	0.295	0.026	0.005
Net Intangible Assets
Total Assets	0.326	0.119	0.371	0.139	0.139
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	2.27	3.28	3.66	3.24	1.93
Total Long Term Debt
Total Debt
Minority Interest
Total Liabilities	3.16	2.88	3.07	2.56	1.93
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-2.83	-2.76	-2.7	-2.42	-1.79
Total Liabilities & Shareholders' Equity	0.326	0.119	0.371	0.139	0.139
Total Common Shares Outstanding
Total Preferred Shares Outstanding